Others have explored the transmigration of T cells in vitro and found greater CD4+ and CD8+ T cell passage across a stimulated blood–brain barrier (BBB) in MS patients compared to healthy controls [5,6]. This evidence concerns the gene CD8A and myeloid sarcoma.